Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s revision/build label was updated from v3.5.2 to v3.5.3, reflecting a routine ClinicalTrials.gov interface/version change rather than a modification to the study record.SummaryDifference0.1%

- Check22 days agoChange DetectedAdded the Drug Saf. 2021 article citation with an erratum and updated the revision label from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check51 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0, reflecting a new version tag rather than content changes.SummaryDifference0.1%

- Check66 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. This change does not affect the study information or user workflows.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No substantive changes to the study details or page layout are visible.SummaryDifference0.1%

- Check94 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.